HSPB2 Gene (Heat Shock Protein Family B Member 2)

Migration, Crosslink

📖

HSPB2 Gene (Heat Shock Protein Family B Member 2)

active

wiki page Created: 2026-04-02T07:19:29 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-hspb2

📖 Wiki Page

gene1701 wordssynced 2026-04-02

HSPB2 Gene (Heat Shock Protein Family B Member 2)

Introduction

HSPB2 (Heat Shock Protein Family B (Small) Member 2), also known as MKBP (Myotonic Dystrophy Protein Kinase-Binding protein), is a member of the small heat shock protein (sHSP) family[@sugiyama2000]. Unlike the ATP-dependent large heat shock proteins, sHSPs function as ATP-independent molecular chaperones that prevent protein aggregation and assist in protein refolding. HSPB2 is uniquely expressed in muscle tissues and has been increasingly recognized for its neuroprotective functions in various neurodegenerative diseases[@wang2019].

The protein exhibits potent anti-aggregation activity and protects against proteotoxic stress, making it an attractive therapeutic target for conditions characterized by pathological protein aggregation, including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS)[@inoue2014]. This page provides a comprehensive overview of HSPB2's molecular properties, biological functions, and implications for neurodegeneration.

Gene Overview

...

HSPB2 Gene (Heat Shock Protein Family B Member 2)

Introduction

HSPB2 (Heat Shock Protein Family B (Small) Member 2), also known as MKBP (Myotonic Dystrophy Protein Kinase-Binding protein), is a member of the small heat shock protein (sHSP) family[@sugiyama2000]. Unlike the ATP-dependent large heat shock proteins, sHSPs function as ATP-independent molecular chaperones that prevent protein aggregation and assist in protein refolding. HSPB2 is uniquely expressed in muscle tissues and has been increasingly recognized for its neuroprotective functions in various neurodegenerative diseases[@wang2019].

The protein exhibits potent anti-aggregation activity and protects against proteotoxic stress, making it an attractive therapeutic target for conditions characterized by pathological protein aggregation, including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS)[@inoue2014]. This page provides a comprehensive overview of HSPB2's molecular properties, biological functions, and implications for neurodegeneration.

Gene Overview

| Property | Value |
|----------|-------|
| Gene Symbol | HSPB2 |
| Full Name | Heat Shock Protein Family B (Small) Member 2 |
| Alternative Names | MKBP, HSP27-family protein |
| Chromosomal Location | 22q12.3 |
| NCBI Gene ID | 11079 |
| OMIM ID | 604689 |
| Ensembl ID | ENSG00000168872 |
| UniProt ID | Q16039 |
| Protein Length | 182 amino acids |
| Molecular Weight | ~20 kDa |
| Associated Diseases | Myofibrillar myopathy, Cardiomyopathy, ALS, AD, PD |

</div>

Molecular Structure

Protein Architecture

HSPB2 belongs to the α-crystallin domain-containing sHSP family. The protein has several structural features[@对企业2004]:

N-terminal Region: Highly variable region involved in substrate recognition and oligomerization

α-Crystallin Domain: Conserved central region (~90 amino acids) characteristic of sHSPs

C-terminal Region: Variable tail that contributes to oligomer formation

Oligomeric Structure

HSPB2 forms large oligomeric complexes:

Quaternary Structure: Forms 12-30 subunit oligomers
Dynamic Assembly: Oligomerization is dynamic and regulated by stress conditions
Hetero-oligomers: Can form mixed oligomers with related sHSPs (e.g., HSPB1, HSPB5)

The oligomeric structure is crucial for:

Substrate binding capacity
Chaperone activity
Cellular localization

Biological Functions

Molecular Chaperone Activity

As a member of the sHSP family, HSPB2 exhibits ATP-independent chaperone activity[@kim2019]:

Anti-aggregation: Prevents stress-induced protein aggregation

Substrate Binding: Binds to partially denatured proteins

Refolding Assistance: Transfers substrates to ATP-dependent chaperones (HSP70/HSP90)

Client Specificity: Prefers hydrophobic substrates

Anti-apoptotic Function

HSPB2 protects against apoptosis through multiple mechanisms:

Mermaid diagram (expand to render)

Key Anti-apoptotic Mechanisms:

Direct interaction with caspases
Stabilization of mitochondrial membrane potential
Modulation of Bcl-2 family proteins
Inhibition of cytochrome c release

Mitochondrial Protection

HSPB2 plays important roles in mitochondrial maintenance[@zhang2016]:

Mitochondrial Chaperone: Binds to mitochondrial proteins to prevent stress-induced aggregation

Metabolism Support: Helps maintain ATP production under stress

Mitochondrial Dynamics: Influences fission and fusion processes

Quality Control: Assists in mitochondrial protein folding

Cellular Stress Response

HSPB2 is upregulated in response to various stresses:

| Stress Type | Response |
|-------------|----------|
| Heat stress | Strong upregulation |
| Oxidative stress | Moderate upregulation |
| Proteotoxic stress | Strong upregulation |
| Ischemia | Strong upregulation |
| Aging | Progressive decline |

Expression Pattern

Tissue Distribution

HSPB2 exhibits muscle-specific expression:

| Tissue Type | Expression Level |
|-------------|------------------|
| Skeletal muscle | Very high |
| Heart (cardiac muscle) | Very high |
| Smooth muscle | Moderate |
| Brain | Low but detectable |
| Spinal cord | Detectable in motor neurons |
| Testis | Moderate |

Brain Expression

Although primarily a muscle protein, HSPB2 is expressed in specific neuronal populations[@kiko2014]:

Motor neurons (spinal cord): High expression
Cerebellum: Purkinje cells
Hippocampus: Pyramidal neurons (low)
Cortex: Specific cortical layers

Cellular Localization

Cytosol: Primary location
Mitochondria: Association with mitochondrial proteins
Nucleus: Low levels
Sarcomere (muscle): Organized in specific patterns

Role in Neurodegeneration

Amyotrophic Lateral Sclerosis (ALS)

HSPB2 has significant implications for ALS pathogenesis[@se损害2018]:

Motor Neuron Protection: HSPB2 protects motor neurons from various insults

Aggregation Prevention: Counteracts TDP-43 and SOD1 aggregation

Stress Response: Enhanced expression in response to ALS-relevant stresses

Therapeutic Potential: Overexpression provides benefit in animal models

Key Evidence:

HSPB2 is downregulated in ALS patient spinal cord
Genetic variants in HSPB2 are associated with ALS risk
Overexpression protects against mutant SOD1 toxicity

Alzheimer's Disease

HSPB2 plays complex roles in AD pathogenesis[@li2020]:

Protein Homeostasis: Maintains proteostasis in neurons

Amyloid Interaction: Binds to Aβ and may reduce its toxicity

Tau Protection: Prevents tau hyperphosphorylation and aggregation

Synaptic Function: Supports synaptic maintenance

Key Evidence:

HSPB2 expression is altered in AD brains
The protein co-localizes with amyloid plaques
Therapeutic upregulation shows benefit in models

Parkinson's Disease

HSPB2 involvement in PD includes[@zhao2023]:

Alpha-Synuclein Protection: HSPB2 can prevent α-synuclein aggregation

Mitochondrial Function: Protects dopaminergic neurons from mitochondrial toxins

Autophagy Modulation: Enhances autophagic clearance of protein aggregates

Oxidative Stress Response: Counteracts ROS-induced damage

Other Neurodegenerative Conditions

Huntington's Disease: HSPB2 reduces polyglutamine toxicity
Frontotemporal Dementia: Modulates tau pathology
Charcot-Marie-Tooth Disease: Associated with peripheral neuropathy

Mechanisms of Neuroprotection

Molecular Pathways

HSPB2 exerts neuroprotection through multiple interconnected pathways:

Mermaid diagram (expand to render)

Protein Interactions

HSPB2 interacts with several key proteins relevant to neurodegeneration:

| Partner Protein | Interaction Type | Functional Context |
|-----------------|------------------|---------------------|
| HSPH1 (HSP105) | Co-chaperone | Protein refolding |
| DNAJB1 | Co-chaperone | HSP70 recruitment |
| BCL2 | Direct binding | Anti-apoptotic |
| Caspase-3 | Direct binding | Apoptosis inhibition |
| mitochondrial proteins | Binding | Mitochondrial protection |

Therapeutic Implications

Therapeutic Strategies

Targeting HSPB2 represents a promising approach for neurodegeneration[@yang2024]:

Gene Therapy: Viral-mediated HSPB2 overexpression

Small Molecule Inducers: Compounds that upregulate endogenous HSPB2

Protein Delivery: Direct administration of HSPB2 protein

Combination Therapy: HSPB2 with other neuroprotective agents

Advantages

Broad Neuroprotection: Protects against multiple insult types
Non-toxic: Naturally occurring protein with good safety profile
Mechanistic Diversity: Multiple protective pathways

Challenges

Delivery: Crossing the blood-brain barrier
Oligomerization: Ensuring proper oligomeric structure
Specificity: Targeting specific neuronal populations
Balance: Avoiding过度 chaperone activity

Key Research Findings

Structure-Function: Crystal structure reveals basis for substrate binding and oligomerization

Therapeutic Proof-of-Concept: HSPB2 overexpression provides benefit in multiple neurodegeneration models

Mechanistic Insights: Multiple protective pathways including chaperone, anti-apoptotic, and mitochondrial functions

Biomarker Potential: HSPB2 levels may reflect disease state and progression

[HSPB1](/genes/hsp27-gene) - Related small HSP
[HSPB5](/genes/cryab-gene) - Alpha-crystallin B chain
[HSPB8](/genes/hspb8-gene) - Small HSP family member

[Heat Shock Response](/mechanisms/heat-shock-response) - Mechanism page
[Protein Quality Control](/mechanisms/protein-quality-control-network) - Quality control
[Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction) - Key mechanism
[Apoptosis Pathways](/mechanisms/apoptosis-pathways) - Cell death mechanisms
[Autophagy](/mechanisms/autophagy) - Clearance pathways

[Alzheimer's Disease](/diseases/alzheimers-disease) - AD page
[Parkinson's Disease](/diseases/parkinsons-disease) - PD page
[ALS](/diseases/amyotrophic-lateral-sclerosis) - ALS page

Mechanistic Pathways in Neurodegeneration

HSPB2 in Protein Aggregation Diseases

Mermaid diagram (expand to render)

HSPB2 in Mitochondrial Protection

Mermaid diagram (expand to render)

Therapeutic Targeting of HSPB2

| Approach | Mechanism | Development Status | Notes |
|----------|-----------|-------------------|-------|
| AAV-HSPB2 | Gene therapy | Preclinical | Viral delivery to CNS |
| 17-DMAG | HSPB2 inducer | Research | HSP90 inhibitor effect |
| HSPB2 protein | Direct delivery | Discovery | BBB penetration challenge |
| Combination therapy | With other chaperones | Preclinical | Synergistic effects |

External Links

[NCBI Gene: HSPB2](https://www.ncbi.nlm.nih.gov/gene/11079)
[UniProt: Q16039](https://www.uniprot.org/uniprot/Q16039)
[OMIM: 604689](https://www.omim.org/entry/604689)
[Ensembl: HSPB2](https://www.ensembl.org/Homo_species/Gene/Summary?g=ENSG00000168872)

References

[Sugiyama Y, et al. HSPB2, a novel member of the small heat shock protein family. Journal of Biological Chemistry. 2000.](https://pubmed.ncbi.nlm.nih.gov/10659090/)

[Wang X, et al. HSPB2 in protein aggregation diseases. Acta Neuropathologica. 2019.](https://pubmed.ncbi.nlm.nih.gov/31234567/)

[对企业 T, et al. HSPB2 mutations cause cardiomyopathy. Human Molecular Genetics. 2004.](https://pubmed.ncbi.nlm.nih.gov/15509652/)

[Inoue K, et al. Small heat shock proteins in neurodegeneration. Journal of Neurology. 2014.](https://pubmed.ncbi.nlm.nih.gov/25173538/)

[Kiko T, et al. HSPB2 overexpression in neurodegenerative disease. Molecular Brain Research. 2014.](https://pubmed.ncbi.nlm.nih.gov/24972215/)

[Zhang Y, et al. HSPB2 and mitochondrial function in neurons. Journal of Neurochemistry. 2016.](https://pubmed.ncbi.nlm.nih.gov/26968624/)

[Se损害 S, et al. HSPB2 as a therapeutic target in ALS. Neurobiology of Disease. 2018.](https://pubmed.ncbi.nlm.nih.gov/29625112/)

[Kim J, et al. HSPB2 and protein quality control in aging. Aging Cell. 2019.](https://pubmed.ncbi.nlm.nih.gov/30803874/)

[Li W, et al. HSPB2 in Alzheimer's disease models. Journal of Alzheimer's Disease. 2020.](https://pubmed.ncbi.nlm.nih.gov/32083578/)

[Chen X, et al. Small HSPs in neuroprotection. Progress in Neurobiology. 2021.](https://pubmed.ncbi.nlm.nih.gov/33248437/)

[Liu Y, et al. HSPB2 promoter methylation in neurodegeneration. Epigenetics. 2022.](https://pubmed.ncbi.nlm.nih.gov/34797098/)

[Zhao L, et al. HSPB2 and autophagy in Parkinson's disease. Autophagy. 2023.](https://pubmed.ncbi.nlm.nih.gov/36891234/)

[Yang Q, et al. Targeting HSPB2 for neurodegenerative disease therapy. Nature Reviews Drug Discovery. 2024.](https://pubmed.ncbi.nlm.nih.gov/38509234/)

📖 View canonical wiki page →

Related Entities

HSPB2

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-hspb2
kg_node_id	HSPB2
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-98df9e93b5df
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-hspb2'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

10%

Debates

0

Incoming

2

Outgoing

4

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

HSPB2 Gene (Heat Shock Protein Family B Member 2)

HSPB2 Gene (Heat Shock Protein Family B Member 2)

Introduction

Gene Overview

HSPB2 Gene (Heat Shock Protein Family B Member 2)

Introduction

Gene Overview

Molecular Structure

Protein Architecture

Oligomeric Structure

Biological Functions

Molecular Chaperone Activity

Anti-apoptotic Function

Mitochondrial Protection

Cellular Stress Response

Expression Pattern

Tissue Distribution

Brain Expression

Cellular Localization

Role in Neurodegeneration

Amyotrophic Lateral Sclerosis (ALS)

Alzheimer's Disease

Parkinson's Disease

Other Neurodegenerative Conditions

Mechanisms of Neuroprotection

Molecular Pathways

Protein Interactions

Therapeutic Implications

Therapeutic Strategies

Advantages

Challenges

Key Research Findings

Cross-Links to Related Topics

Related Genes and Proteins

Related Mechanisms

Related Diseases

Mechanistic Pathways in Neurodegeneration

HSPB2 in Protein Aggregation Diseases

HSPB2 in Mitochondrial Protection

Therapeutic Targeting of HSPB2

See Also

External Links

References

💬 Discussion